These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 10949328

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK, Kim CT, Song SD.
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R, Al-Sharif N, Al-Sayegh MO, Osman MM, Shaikh MA.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [Abstract] [Full Text] [Related]

  • 10. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The treatment of multidrug-resistant tuberculosis in Turkey.
    Tahaoğlu K, Törün T, Sevim T, Ataç G, Kir A, Karasulu L, Ozmen I, Kapakli N.
    N Engl J Med; 2001 Jul 19; 345(3):170-4. PubMed ID: 11463011
    [Abstract] [Full Text] [Related]

  • 13. The treatment results of patients with multidrug resistant tuberculosis and factors affecting treatment outcome.
    Karagöz T, Yazicioğlu Moçin O, Pazarli P, Senol T, Yetiş Duman D, Duman G, Saltürk C, Unal O, Halezeroğlu S.
    Tuberk Toraks; 2009 Jul 19; 57(4):383-92. PubMed ID: 20037853
    [Abstract] [Full Text] [Related]

  • 14. A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam.
    Lan NTN, Lademarco MF, Binkin NJ, Tung LB, Quy HT, Cĵ NV.
    Int J Tuberc Lung Dis; 2001 Jun 19; 5(6):575-8. PubMed ID: 11409587
    [Abstract] [Full Text] [Related]

  • 15. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China].
    Hu Y, Jiang WL, Wang WB, Xu B.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun 19; 29(6):540-4. PubMed ID: 19040032
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
    Cimen NO, Arslan Z, Saygi A, Ocak K, Babacan F, Kurutepe M.
    Int J Tuberc Lung Dis; 2009 Jul 19; 13(7):907-13. PubMed ID: 19555543
    [Abstract] [Full Text] [Related]

  • 18. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Koh WJ, Kwon OJ, Gwak H, Chung JW, Cho SN, Kim WS, Shim TS.
    J Antimicrob Chemother; 2009 Aug 19; 64(2):388-91. PubMed ID: 19468028
    [Abstract] [Full Text] [Related]

  • 19. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
    Ormerod LP.
    Br Med Bull; 2005 Aug 19; 73-74():17-24. PubMed ID: 15956357
    [Abstract] [Full Text] [Related]

  • 20. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L, Zheng SH, Chu NH, Xie YG, Yang YZ, Li Q, Wang XM, Yan XL, Tan WG, Miao ZP, Duanmu HJ.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3387-91. PubMed ID: 19159566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.